Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiomegaly » Cardiomyopathy, Dilated
Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiomyopathies » Cardiomyopathy, Dilated
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Laminopathies » Cardiomyopathy, Dilated
Description
A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. MeSH
Hierarchy View
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (10)
Organization Involved with Phase 4 Indications (32)
Organization Involved with Phase 3 Indications (23)
Organization Involved with Phase 2 Indications (43)
Bambino Gesù Hospital and Research Institute
Blood Transfusion Centre of Slovenia
Icahn School of Medicine at Mount Sinai
Medical City Children's Hospital, Dallas
Methodist Cancer Center, Houston, Texas
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (13)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.